(Q43794732)

26 November 2017

Vincristine pharmacokinetics is related to clinical outcome in children with standard risk acute lymphoblastic leukemia (English)

1 reference

26 November 2017

1 reference

1 reference

3

1 reference

26 November 2017

Gudmar Lönnerholm

1

1 reference

26 November 2017

Britt-Marie Frost

2

1 reference

26 November 2017

Mikael Behrendtz

4

1 reference

26 November 2017

Anders Castor

5

1 reference

26 November 2017

Erik Forestier

6

1 reference

26 November 2017

Mats Heyman

7

1 reference

26 November 2017

Donald R A Uges

8

1 reference

26 November 2017

Siebold S N de Graaf

9

1 reference

26 November 2017

language of work or name

English

0 references

publication date

4 June 2008

1 reference

British Journal of Haematology

26 November 2017

1 reference

26 November 2017

142

1 reference

26 November 2017

4

1 reference

26 November 2017

616-621

1 reference

The management of high-risk lymphoblastic leukaemia in children

26 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07235.X

Pharmacokinetics of vincristine in children and adolescents with acute lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07235.X

A program package for simulation and parameter estimation in pharmacokinetic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07235.X

Selective metabolism of vincristine in vitro by CYP3A5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07235.X

Vincristine pharmacokinetics after repetitive dosing in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07235.X

Vincristine disposition in children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07235.X

Pharmacokinetics of vincristine monotherapy in childhood acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07235.X

Vincristine pharmacokinetics and response to vincristine monotherapy in an up-front window study of the Dutch Childhood Leukaemia Study Group (DCLSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07235.X

Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07235.X

An automated method for the bioanalysis of vincristine suitable for therapeutic drug monitoring and pharmacokinetic studies in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07235.X

Influence of functional polymorphisms of the MDR1 gene on vincristine pharmacokinetics in childhood acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07235.X

10.1111/J.1365-2141.2008.07235.X

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference